147 related articles for article (PubMed ID: 23873316)
1. Primary immune deficiencies: practical questions.
Gouilleux-Gruart V; Schleinitz N; Fischer A
Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S67-78. PubMed ID: 23873316
[No Abstract] [Full Text] [Related]
2. Management of secondary immune deficiencies: what is the role of immunoglobulins?
Mouthon L; Fermand JP; Gottenberg JE
Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S56-67. PubMed ID: 23873315
[No Abstract] [Full Text] [Related]
3. [Immunotherapy in non-allergic diseases].
Español T
Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
[TBL] [Abstract][Full Text] [Related]
4. New uses for IVIgG immunoglobulin therapies.
Wallington T
Vox Sang; 2004 Jul; 87 Suppl 2():155-7. PubMed ID: 15209904
[No Abstract] [Full Text] [Related]
5. The question of when and how. Foreword.
Alam R
Immunol Allergy Clin North Am; 2008 Nov; 28(4):xiii-xiv. PubMed ID: 18940568
[No Abstract] [Full Text] [Related]
6. Audit of the use of intravenous immunoglobulin for antibody deficiencies in a Clinical Immunology Unit.
Arriaran L; Gil J; Fernandez-Cruz E; Carbone J
Allergol Immunopathol (Madr); 2015; 43(2):220-2. PubMed ID: 24726086
[No Abstract] [Full Text] [Related]
7. Primary immunodeficiency: a never ending story.
Etzioni A; Fuleihan R
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):503-4. PubMed ID: 21971336
[No Abstract] [Full Text] [Related]
8. [Immunomodulatory effects of intravenous immunoglobulins].
Kazatchkine M; Mouthon L; Kaveri SV
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
[TBL] [Abstract][Full Text] [Related]
9. [Indications for intravenous immunoglobulins].
Spertini F
Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
[No Abstract] [Full Text] [Related]
10. The role of intravenous immunoglobulins in pediatric diseases.
Ramasubramanian KV; Kumar A; Kabra SK; Seth V
Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
[No Abstract] [Full Text] [Related]
11. Advances in the treatment of primary and secondary immune deficiences.
Kaveri S
Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S51-2. PubMed ID: 23873313
[No Abstract] [Full Text] [Related]
12. Immunoglobulin therapy: methods of delivery.
Ballow M
J Allergy Clin Immunol; 2008 Nov; 122(5):1038-9. PubMed ID: 18804269
[No Abstract] [Full Text] [Related]
13. [Substitution therapy for deficiencies in antibody production by immunoglobulins].
Strengers PF
Arch Pediatr; 1999; 6 Suppl 2():423s-424s. PubMed ID: 10370557
[No Abstract] [Full Text] [Related]
14. [The indications for intravenous immunoglobulins in pediatric practice].
Popescu V; Bleahu D
Pediatrie (Bucur); 1992; 41(1):37-45. PubMed ID: 1322724
[TBL] [Abstract][Full Text] [Related]
15. Characterization and potential clinical applications of autoantibodies against cytokines.
de Lemos Rieper C; Galle P; Hansen MB
Cytokine Growth Factor Rev; 2009 Feb; 20(1):61-75. PubMed ID: 19213592
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
Suez D
J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
[TBL] [Abstract][Full Text] [Related]
17. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomics of immunoglobulins and indications for their use.
Guillevin L
Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S53-5. PubMed ID: 23873314
[No Abstract] [Full Text] [Related]
19. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline.
Shehata N; Palda V; Bowen T; Haddad E; Issekutz TB; Mazer B; Schellenberg R; Warrington R; Easton D; Anderson D; Hume H
Transfus Med Rev; 2010 Jan; 24 Suppl 1():S28-50. PubMed ID: 19962579
[TBL] [Abstract][Full Text] [Related]
20. Immune modulators as adjuncts for the prevention and treatment of invasive fungal infections.
Pikman R; Ben-Ami R
Immunotherapy; 2012 Dec; 4(12):1869-82. PubMed ID: 23240754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
